Evidence map›Paper›PMID 39404432›Full record

ArticleCells2024

Investigating the p21 Ubiquitin-Independent Degron Reveals a Dual Degron Module Regulating p21 Degradation and Function.

Marianna Riutin, Pnina Erez, Julia Adler, Assaf Biran, Nadav Myers, Yosef Shaul

Abstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marianna RiutinDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot P.O. Box 26, Israel.
Pnina ErezDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot P.O. Box 26, Israel.
Julia AdlerDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot P.O. Box 26, Israel.
Assaf BiranDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot P.O. Box 26, Israel.
Nadav MyersDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot P.O. Box 26, Israel.
Yosef ShaulDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot P.O. Box 26, Israel.ORCID 0000-0002-0545-6512

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A group of intrinsically disordered proteins (IDPs) are subject to 20S proteasomal degradation in a ubiquitin-independent manner. Recently, we have reported that many IDPs/IDRs are targeted to the 20S proteasome via interaction with the C-terminus of the PSMA3 subunit, termed the PSMA3 Trapper. In this study, we investigated the biological significance of the IDP-Trapper interaction using the IDP p21. Using a split luciferase reporter assay and conducting detailed p21 mutagenesis, we first identified the p21 RRLIF box, localized at the C-terminus, as mediating the Trapper interaction in cells. To demonstrate the role of this box in p21 degradation, we edited the genome of HEK293 and HeLa cell lines using a CRISPR strategy. We found that the p21 half-life increased in cells with either a deleted or mutated p21 RRLIF box. The edited cell lines displayed an aberrant cell cycle pattern under normal conditions and in response to DNA damage. Remarkably, these cells highly expressed senescence hallmark genes in response to DNA damage, highlighting that the increased p21 half-life, not its actual level, regulates senescence. Our findings suggest that the p21 RRLIF box, which mediates interactions with the PSMA3 Trapper, acts as a ubiquitin-independent degron. This degron is positioned adjacent to the previously identified ubiquitin-dependent degron, forming a dual degron module that functionally regulates p21 degradation and its physiological outcomes.

Indexed as

Cyclin-Dependent Kinase Inhibitor p21Proteasome Endopeptidase ComplexProteolysisUbiquitinCell CycleCellular SenescenceDegronsDNA DamageHEK293 CellsHeLa CellsHumansCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21Proteasome Endopeptidase ComplexPSMA3 protein, humanUbiquitin20S proteasome targetingCDKN1A and p21WAF1/Cip1 degradationubiquitin-independent degradation

Identifiers

PMID39404432
PMCPMC11476297

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.